Short Summary
Liberty Energy and U.S. Well Services settled their IPR dispute over patent 11,208,878, resulting in a joint motion to terminate the proceeding. The Board granted termination and kept the settlement confidential.
Detailed Summary
In IPR2025-00139 concerning U.S. Patent No. 11,208,878, Liberty Energy, Inc. and Liberty Oilfield Services LLC reached a settlement with patent owner U.S. Well Services, LLC. Both parties filed a joint motion to terminate the inter partes review, citing a settlement agreement that resolves all related patent office and district court matters. The Patent Trial and Appeal Board found good cause to terminate the proceeding and ordered the settlement agreement to be treated as confidential business information under 37 C.F.R. § 42.74(c). No substantive decision on patent validity was rendered.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Liberty Energy Inc. et al. vs U.S. Well Services, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
OnePlus Technology (Shenzhen) Co., Ltd. et al.vsPantech Corporation
OnePlus has filed an IPR petition seeking cancellation of ten claims of Pantech’s U.S. Patent 8,995,372, arguing that the claims are obvious over prior‑art references covering carrier‑aggregation random access.
Accelight Technologies, Inc. et al.vsApplied Optoelectronics, Inc.
Applied Optoelectronics successfully opposed Accelight Technologies’ request for director review, arguing the March 11 memo was inapplicable and that the petition’s grounds were weak. The PTAB upheld the director’s discretionary denial of institution for the IPR.
AT&T Services Inc. et al.vsRightQuestion, LLC
AT&T, Verizon and Nokia have filed an IPR petition seeking to invalidate RightQuestion's 2023 patent on automatic number identification. They assert that the claims are obvious over prior art references Har, Miller and French, and argue that the Board should institute the review under favorable Fintiv factors.
Deltran USA LLC et al.vsThe Noco Company
The PTAB held that all eight challenged claims of the Noco Company’s jump‑starter patent are obvious over a combination of prior‑art references, rendering them unpatentable.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB held that all nine claims of Inari Medical’s hemostasis‑valve patent are unpatentable, finding anticipation and obviousness over Schaffer and its combinations with Hartley, Eller, and Garrison.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.